Form 4 for ETON Eton Pharmaceuticals, Inc.
Accepted 2026-07-13 16:36:01 ET · period of report 2026-07-12 · accession 0001437749-26-023440 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-07-13 16:36 | 2026-07-12 | ETON | Krempa David | Chief Business Off | M - OptEx | — | +10.0K | 37.0K | +37% | — |
| D | 2026-07-13 16:36 | 2026-07-12 | ETON | Krempa David | Chief Business Off | M - OptEx | $0.00 | -10.0K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-07-12 | M | A | 10,000 | — | 37,025 | D | — | — | (F1) On July 12, 2022, the reporting person was granted 40,000 restricted stock units which vested in four equal annual installments beginning July 12, 2023. |
| 2 | Derivative | Restricted Stock Units | 2026-07-12 | M | D | 10,000 | $0.00 | 0 | D | $0.00 · — to — | 10,000 Common Stock | (F1) On July 12, 2022, the reporting person was granted 40,000 restricted stock units which vested in four equal annual installments beginning July 12, 2023. (F1) On July 12, 2022, the reporting person was granted 40,000 restricted stock units which vested in four equal annual installments beginning July 12, 2023. |